This study demonstrated that BJT ameliorated psoriasis-like inflammation by concurrently regulating pivotal pro-inflammatory cytokines and two distinct steps of the AA pathway, which may be related to its multi-component composition. These findings indicate the therapeutic potential of the multi-component drug BJT on multiple targets for psoriasis-like inflammation.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: